DP, C., GA, C., AÍS, N., AR, Q., LRC, N., L, C., . . . MCX, P. (2026). GlyT1 (SLC6A9) inhibition in neurological and psychiatric disorders. Naunyn-Schmiedeberg's archives of pharmacology. https://doi.org/10.1007/s00210-026-05276-y
Chicago Style (17th ed.) CitationDP, Cavalcante, Carvalho GA, Nunes AÍS, Quintanilha AR, Nascimento LRC, Caixeta L, Ulrich H, Gomez RS, and Pinto MCX. "GlyT1 (SLC6A9) Inhibition in Neurological and Psychiatric Disorders." Naunyn-Schmiedeberg's Archives of Pharmacology 2026. https://doi.org/10.1007/s00210-026-05276-y.
MLA (9th ed.) CitationDP, Cavalcante, et al. "GlyT1 (SLC6A9) Inhibition in Neurological and Psychiatric Disorders." Naunyn-Schmiedeberg's Archives of Pharmacology, 2026, https://doi.org/10.1007/s00210-026-05276-y.